首页|茵栀黄颗粒结合酪酸梭菌活菌散治疗新生儿病理性黄疸临床研究

茵栀黄颗粒结合酪酸梭菌活菌散治疗新生儿病理性黄疸临床研究

扫码查看
目的 研究茵栀黄颗粒结合酪酸梭菌活菌散治疗新生儿病理性黄疸临床效果。方法 研究纳入新生儿病理性黄疸总计142例(2021年2月-2023年2月收治),将患儿以随机数字表法分为观察组与对照组,各组71例,入组患儿均给予蓝光照射治疗,对照组患儿同时采取酪酸梭菌活菌散治疗,观察组患儿在对照组治疗基础上结合茵栀黄颗粒治疗,各组患儿数据观察:治疗效果、治疗前后血清胆红素水平变化及中医症候积分(面目皮肤发黄、不欲吮乳、唇干、小便深黄、大便白如陶土等)变化、黄疸消退时间及住院时间、免疫功能指标变化、不良反应。结果 观察组患儿与对照组总有效率比较(97。18%vs88。73%),P<0。05;治疗前,各组患儿血清总胆红素(Total bilirubin,TBil)及间接胆红素(Indirect bilirubin,IBil)、结合胆红素(Bound bilirubin,DBil)等胆红素指标、中医症候积分(面目皮肤发黄、不欲吮乳、唇干、小便深黄、大便白如陶土等)、CD4+T淋巴细胞、CD8+T淋巴细胞、CD4+/CD8+等比较,P>0。05,治疗后各组患者TBil、IBil、DBil、中医症候积分(面目皮肤发黄、不欲吮乳、唇干、小便深黄、大便白如陶土等)等指标均下降,CD4+、CD4+/CD8+均上升,观察组患儿治疗后TBil、IBil、DBil、中医症候积分(面目皮肤发黄、不欲吮乳、唇干、小便深黄、大便白如陶土等)等指标低于对照组,CD4+、CD4+/CD8+等指标高于对照组,P<0。05;与对照组患儿黄疸消退时间及住院时间比较,观察组患儿各项时间均更短,P<0。05;两组患儿不良反应率均较低,P>0。05。结论 茵栀黄颗粒结合酪酸梭菌活菌散治疗新生儿病理性黄疸临床效果显著,患儿症状改善,恢复快,患儿免疫功能改善,且治疗安全性高,值得应用。
Clinical of Yinzhihuang Granules(茵栀黄颗粒)Combined with Clostridium Caseinate Live Powder in Treatment of Neonatal Pathological Jaundice
Objective To study the clinical effect and safety of Yinzhihuang Granules(茵栀黄颗粒)combined with Clostridi-um Caseinate Live Powder in the treatment of neonatal pathological jaundice.Methods A total of 142 cases of neonatal pathologi-cal jaundice(admitted from February 2021 to February 2023)were included in this study.The children were divided into obser-vation group and control group by random number table method,with 71 cases in each group.All the enrolled children were trea-ted with blue light irradiation,while the control group were treated with Live Clostridium Caseinate Powder.The observation group combined with Yinzhihuang Granules on the basis of the control group.The treatment effect,serum bilirubin level changes before and after treatment and traditional Chinese medicine syndrome scores(yellow complexion and skin,reluctance to suckle,dry lips,deep yellow urine,white stool like clay,etc.)changes,jaundice regression time and hospital stay,immune function index changes and adverse reactions of two groups were compared.Results The total effective rates of observation group and control group were 97.18%vs 88.73%(P<0.05).Before treatment,the levels of total bilirubin(TBil),indirect bilirubin(IBil),bound bilirubin(DBil),total bilirubin(TBIL)and indirect bilirubin(IBIL)and other bilirubin indexes were detected in two groups.TCM syn-drome scores(yellow complexion and skin,reluctance to suckle,dry lips,deep yellow urine,white stool like clay,etc.),CD4+T lymphocytes,CD8+T lymphocytes and CD4+/CD8+were not significant(P>0.05).After treatment,the levels of TBil,IBil and DBil,TCM syndrome scores(yellow complexion and skin,reluctance to suckle,dry lips,deep yellow urine,white stool like clay,etc.)were all decreased in two groups,and the values of CD4+and CD4+/CD8+were all increased.After treatment,the levels of TBil,IBil and DBil,TCM syndrome scores(yellow complexion and skin,reluctance to suckle,dry lips,deep yellow urine,white stool like clay,etc.)in the observation group were lower than those in the control group,and the values of CD4+and CD4+/CD8+were higher than those in the control group(P<0.05).Compared with that of fhe control group,the duration of jaundice resolution and hospitalization was shorter in the observation group(P<0.05).The adverse reaction rate was lower in both groups(P>0.05).Conclusion Yinzhihuang Granules combined with Clostridium Caseinate Live Powder in the treatment of neonatal pathological jaundice has significant clinical effect.The symptoms of the patients can be improved.The recovery is fast,the im-mune function of the patients can be improved,and the treatment safety is high,which is worthy of applying

neonatal pathological jaundiceYinzhihuang Granules(茵栀黄颗粒)Clostridium Caseinate Live Powderbiliru-binTCM symptom scoreimmune functionadverse reaction

王向平、张泽佳、陈占芳

展开 >

大同市第一人民医院,山西大同 037004

新生儿病理性黄疸 茵栀黄颗粒 酪酸梭菌活菌散 胆红素 中医症候积分 免疫功能 不良反应

2024

中华中医药学刊
中华中医药学会 ,辽宁中医药大学

中华中医药学刊

CSTPCD北大核心
影响因子:1.007
ISSN:1673-7717
年,卷(期):2024.42(9)